Eli Lilly and Co (WBO:LLYC) Gross Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:LLYC Eli Lilly and Co WBO:LLYC
82 GF Score
Price €970.30
GF Value €1,358.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Eli Lilly and Co Gross Loan?

Gross Loan only applies to banks.

WBO:LLYC
82GF Score
Eli Lilly and Co WBO:LLYC
Gross Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eli Lilly and Co (WBO:LLYC) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of €970.30 is trading 28.6% below its estimated GF Value™ of €1,358.57. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for WBO:LLYC:

  • Gross Loan:
  • GF Value™: €1,358.57 vs. price of €970.30 (28.6% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the WBO:LLYC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
82GF Score

Get the complete analysis for WBO:LLYC

Gross Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€970.30
Price
€1,358.57
GF Value